Re-evaluating colchicine benefits and recommendations

Debate

Jul 8
Re-evaluating colchicine benefits and recommendations
Kevin R. Bainey, Xavier Rossello
A large randomized clinical trial in patients with myocardial infarction yielded neutral results for the use of colchicine, raising concerns about its true clinical benefit in patients with atherosclerotic cardiovascular disease.

NEW ISSUE

Jul 7
A new issue of EuroIntervention

With an expert review on the state of robotics in structural heart interventions, this issue of EuroIntervention also includes a debate on whether colchicine benefits and recommendations should be re-evaluated. In original research: articles on antithrombotic strategies for microembolisms post-TAVI; intra- vs supra- annular self-expanding valves in small aortic annuli; and the 4-year Myval durability outcomes using Valve Academic Research Consortium-3 criteria. There is a research correspondence using serial OCT to define restenosis patterns after PCI with drug-coated balloons; a flashlight on intravascular lithotripsy for proximal cap ambiguity in CTO PCI; news from the EAPCI; and more...

A new issue of EuroIntervention

Flashlight

Jul 7
“Stone whisper” technique
Maximilian Will, Konstantin Schwarz, et al.
A 74-year-old male with heart failure and left ventricular ejection fraction of 40% presented with exertional chest pain and dyspnea. Coronary angiography revealed a chronic total occlusion in a large side branch of the left anterior descending artery, which was successfully treated using the 'stone whisper technique' of intravascular lithotripsy.
“Stone whisper” technique

Letter to the Editor

Jul 4
REPLY: Completeness or complexity?
Claudio Laudani, Davide Capodanno, et al.
This manuscript discusses the challenges in assessing the impact of complete revascularization in STEMI patients, highlighting the limitations of available data and the importance of considering disease complexity.
free

Letter to the Editor

Jul 3
LETTER: Completeness or complexity?
Alessandro Sticchi, Giuseppe Biondi-Zoccai
The study by Laudani et al. examined complete revascularization strategies in acute myocardial infarction with multivessel disease, but the authors raise concerns about the potential dilution or exaggeration of true treatment effects due to heterogeneous trial designs and patient populations.
free

Original Research

Jul 2
Chimney stenting for redo-TAVI
Alessandro Beneduce, Dariusz Dudek, et al.
This ex vivo study evaluated the feasibility and outcomes of chimney stenting during redo-TAVI, finding that interactions between the coronary stents and the index TAV frames or aortic wall led to stent distortion and underexpansion, which could compromise procedural efficacy and future coronary access.
Chimney stenting for redo-TAVI

#EIJonAir

Jun 30
#EIJOnAir - Leaflet modification techniques during TAVI

Don't miss our upcoming live X video chat on Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation with Sunny Goel and Alessandro Sticchi.

Join us live on our social media channels Wednesday 2 July at 5:30 PM (CET - Paris time).

#EIJOnAir - Leaflet modification techniques during TAVI
Meet Cory, your AI Assistant!
Enhance your reading experience and get deeper insights on complex topics.
Learn more


EuroIntervention's Impact Factor

Jun 19
EuroIntervention's Impact Factor

We are pleased to share that EuroIntervention has achieved a new Impact Factor of 9.5, the highest in its 20-year history, confirming its place in the top quartile of cardiovascular publications with a ranking of 16 among 230 cardiology journals. This notable rise reflects the high standards of the Editorial Board and the ongoing contributions of our authors, reviewers, and readers.


Receive our newsletter
Subscribe banner

Research Correspondence

Jun 27
Next-day discharge following TAVI via alternative access
Yohanna John Zendo, Rodrigo Bagur, et al.

This study found that next-day and 48-hour discharge following alternative access transcatheter aortic valve implantation were safe, with similar 30-day outcomes in terms of readmissions and mortality, supporting the expansion of these early discharge pathways for all TAVI patients.

Next-day discharge following TAVI via alternative access

Expert Consensus

Jun 25
Antithrombotics and ACS in women
Valeria Paradies, Jolanta M. Siller-Matula, et al.

This article highlights the need for increased awareness of sex-specific risks and biases in the management of acute coronary syndrome, with a focus on sex-specific bleeding mitigation strategies, appropriate antithrombotic management, and improving female representation in cardiovascular trials.

Antithrombotics and ACS in women
open access

Original Research

Jun 23
Pacemaker implantation in TAVI for AR
Hendrik Wienemann, Matti Adam, et al.
This retrospective study found that 24.1% of patients without prior pacemaker required new permanent pacemaker implantation after transcatheter aortic valve implantation with the JenaValve Trilogy System for aortic regurgitation, with pre-existing conduction disturbances as independent predictors.
Pacemaker implantation in TAVI for AR

Original Research

Jun 20
Short DAPT in HBR patients with diabetes
Angelo Oliva, Roxana Mehran, et al.
This content covers various interventional procedures and therapies used in cardiology, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.
Short DAPT in HBR patients with diabetes

Debate

Jun 18
Should QFR guidelines change?
William F. Fearon, Simone Biscaglia
The content discusses the use of quantitative flow ratio (QFR), a non-invasive angiography-derived tool, for the assessment of intermediate coronary stenoses, and the ongoing debate on its performance compared to fractional flow reserve (FFR).

NEW ISSUE

Jun 16
A new issue of EuroIntervention

In this issue of EuroIntervention, there is an expert consensus from the EAPCI and the ESC Working Group on Thrombosis on antithrombotics and ACS in women. This issue also includes a debate on the current quantitative flow ratio guidelines. In original research, we look at short dual antiplatelet therapy in high bleeding risk patients with diabetes, pacemaker implantation in TAVI for aortic regurgitation, and chimney stenting in redo-TAVI. In a research correspondence, next-day discharge following TAVI via alternative vascular access is discussed. There is also a flashlight on transcaval transcatheter aortic valve implantation via left-sided venous access and a letter to the editor, news from EAPCI; and more...

A new issue of EuroIntervention

Trending articles
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
42

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
26.5

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved